01 July 2005 : Extended abstract from EFAS 2011
Possible induction of oral allergy syndrome during specific immunotherapy inpatients sensitive to tree pollen.Marek Modrzyński, Edward Zawisza
Med Sci Monit 2005; 11(7): CR351-355 :: ID: 16984
Background: Many studies have shown that specific immunotherapy may preventthe development of allergies to new allergens. Recently, however, there have been sporadic reports onthe possibility of new allergies developing during immunotherapy. The aim of this study was to evaluatethe possibility of the occurrence of food allergy and changes of sIgE concentration in patients sensitiveto tree pollen during specific immunotherapy Material/Methods: We examined 12 patients subjected to desensitizationtreatment of pollinosis caused by allergy to the pollen of Betulaceae trees, in whom only Bet v 1 sIgEwas found in serum prior to immunotherapy. The control group included 8 allergic patients who did notconsent to this treatment. Results: Bet v 2 sIgE was detected after 6 months in 3 patients (25%) andafter 18 months in another 2 patients (41.7% total). In 2 cases, oral allergy syndrome (OAS) occurredin the course of therapy. These findings were accompanied by a concomitant decrease in nasal and ocularallergic signs during the birch pollen season in the overwhelming majority of patients (91.7%). In thecontrol group, no serum occurrence of Bet v 2 sIgE was found during the 18-month observation period.Although no OAS signs appeared in any patient, the symptomatic intensity of pollinosis was not reduced.Conclusions: Due to the limitations of currently used vaccines, new allergies may be induced during immunotherapy.In sporadic cases these may be accompanied by the occurrence of specific clinical manifestations, usuallymild.
Keywords: Betula - immunology, Desensitization, Immunologic - adverse effects, Food Hypersensitivity - etiology, Food Hypersensitivity - immunology, Hypersensitivity - immunology, Hypersensitivity - therapy, Immunoglobulin E - blood, Pollen - immunology, Syndrome, Betula - immunology, Desensitization, Immunologic - adverse effects, Food Hypersensitivity - immunology, Hypersensitivity - therapy, Immunoglobulin E - blood, Pollen - immunology, Syndrome
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952